Loading…
DIA Europe 2019 has ended
Back To Schedule
Thursday, February 7 • 12:00 - 13:15
#S0607: Assessing the Value of a Cure: Are HTA Approaches and Payment Models Fit for Purpose?

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Session

In this session we discuss how to prove value, establish a price, payment models

Chair

Koen Torfs

Speaker

Panel discussion
Charlotte Anderberg, PhD, MSc

Panel discussion
Francis Arickx

Panel discussion
Michael Schlander

Panel discussion
Steve Wooding

Panel discussion
Olivier Wong, MD


Speakers
avatar for Charlotte Anderberg

Charlotte Anderberg

Pharmaceutical Assessor, Dental and Pharmaceutical Benefits Agency
Charlotte Anderberg, PhD, MSc, works as a Pharmaceutical Assessor at the Dental and Pharmaceutical Benefits Agency, TLV, in Stockholm. She has a PhD in Medical Science based on her work on the tumor microenvironment and an MSc in Biomedicine, both from Karolinska Institutet. At TLV... Read More →
avatar for Francis Arickx

Francis Arickx

Head of the Directorate Pharmaceutical Policy, National Institute for Health and Disability Insurance (RIZIV-INAMI)
Francis Arickx is head of the directorate Reimbursement of Medicines and Pharmaceutical Policy within the Health Care Department at the National Institute for Health and Disability Insurance (NIHDI RIZIV/INAMI) in Belgium. He manages administrative and scientific assessments, and... Read More →
MS

Michael Schlander

Head of the Division of Health Economics, German Cancer Research Center (DKFZ), Germany
KT

Koen Torfs

Head of Market Access & Pricing, Actelion
avatar for Olivier Wong

Olivier Wong

CMO, Medi-Qualite Omega
Olivier Wong is Chief Medical Officer at Medi-Qualité Omega (M?Q), France, and an HTA expert. He was a voting member of the Transparency Committee (French national HTA and reimbursement committee with 13 years in office and former fully pledged member of the French National Payer... Read More →
SW

Steve Wooding

Head, Global Commercial and Market Access Strategy Organisation, Janssen

Thursday February 7, 2019 12:00 - 13:15 CET
G1 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  06 Access to Medicines, Session
  • Featured Topics Value and Access
  • Tags Session